Tag
Telehealth
3 articles
Hims & Hers Beats Revenue Estimates but Cuts Profit Forecast on Growth Spending
Q2 revenue of $753.2 million topped estimates by 7.8 percent, but a trimmed full-year adjusted EBITDA forecast sent shares down 9.7 percent.

Teladoc Faces Competitive Pressure as Growth Slows, Reimbursement Tightens
Teladoc's stretched valuation and profitability challenges make it a risky bet as telehealth adoption normalizes
Hims & Hers Jumps on Peptide Reassessment: Multi-Billion Dollar Opportunity Unlocked
Hims & Hers Health, Inc. stock rallied sharply today after the U.S. government confirmed it would reassess the regulatory framework for popular peptides, signaling a substantial expansion opportunity for the telehealth provider.